Vineti Stock

vineti.comHealthcare / Healthcare softwareFounded: 2016Funding to Date: $107.72MM

Vineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies. This company was founded by Razmik Abnous, Amy DuRoss, Malek Faham, Heidi Hagen, Stephen Ting in 2016 and is headquartered in San Francisco, CA. Vineti's software solution Personalized Therapy Management (patent pending) automates patient-centric supply chains for a wide range of advanced therapies, in all phases of clinical development and commercial operations.

Register To Buy and Sell Shares

For more details on financing and valuation for Vineti, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Vineti’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Vineti.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Joe DePinto
Chief Commercial Officer
Brett Robertson
Chief Financial Officer
Amy DuRoss
Co-Founder & Chief Executive Officer
Phil Calvin
Chief Technology Officer
Subbu Viswanathan
Compliance Officer & SVP, Quality, Security & Compliance
Louise Rose Pacini
Chief Operations Officer
Heidi M. Hagen
Co-Founder

Board Members

Eli Casdin
Casdin Capital
Neil Kurtz
Medidata
Michael Pellini
Section 32
John kontor
Optum
Nina Kjellson
Canaan Partners
Michele Holcomb
Cardinal Health
Emily Melton
Threshold Ventures

Frequently Asked Questions About Vineti’s Stock

plusminus
Can you buy Vineti’s stock?
Vineti is not publicly traded on NYSE or NASDAQ in the U.S. To buy Vineti’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Vineti’s stock?
Yes, you can sell stock of a private company like Vineti. Forge can help you sell your Vineti stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Vineti’s stock price?
Vineti is a privately held company and therefore does not have a public stock price. However, you may access Vineti’s private market stock price with Forge Data.
plusminus
What is Vineti’s stock ticker symbol?
Vineti does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Vineti announces agreement with Imvax to utilize Vineti's PTM Essentials™ solution
Vineti’s enterprise technology will enable critical patient-specific Chain of Custody management for Imvax, supporting Imvax’s goal of reaching more...
Drugmakers flock to Vineti's fix for a cell, gene therapy problem
A coalition of drugmakers has agreed to work with Vineti, a San Francisco-based technology company, to usher in new standards that could ease some of the safety and logistic concerns surrounding advanced medicines like cell and gene therapies.
Vineti Extends Series C Funding Round to $68M with an Expanded Investor Coalition
This $33 million extension to Vineti’s Series C in February 2020 will be used to further grow the company’s leading enterprise platform for advanced...
Updated on: Apr 14, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.